- Supplier site
- Group of sites (click to zoom)
Scientist.com supplier network (site locations)
Research supplier
Veracyte
Veracyte is listed as a small business research supplier in the Scientist.com network, with 1 site in 1 country and 1 service area.
Sign in to Scientist.com to open this supplier in your organization's marketplace.
Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Services
What this research supplier says it provides, as listed in the Scientist.com network.
Type of company: Small business
Biomarkers
- Prognostic Biomarkers Discovery Identify candidate biomarkers representative of disease progression without treatment.
Data Science/Bioinformatics
- Clinical Companion Diagnostics Analysis The process of finding patients who are likely to respond positively to a drug and designing a diagnostic tool to identify this group of patients before or with a therapy.
In Vitro Assays
- Assay Development Construct or create new assays or modify existing ones.
- In Vitro Assay Development Develop innovative assay and screening methods outside a living organism to enable a wide range of pre-clinical activities.
In Vitro Pharmacology
- Immuno-oncology Assays Use biochemical, cell based or in vivo assays to measure the activity of immuno-therapy targets.
Real World Evidence & Data
- RWD - Oncology Data from oncology patients, can include clinical treatment, diagnosis, among others.
Service areas:
Where it operates
Sites by country, with the cities in each.
-
United States 1 site
About this supplier
In the supplier's own words, as listed in the Scientist.com network.
The novel Gene Expression Classifier (GEC), the centerpiece of the Afirma Thyroid FNA Analysis, helps physicians reduce the number of avoidable surgeries by preoperatively identifying benign nodules among those that were originally classified by cytopathology as indeterminate. The GEC measures the expression of 142 genes and applies a multi-dimensional algorithm to reclassify a nodule with cytopathology indeterminate diagnosis as benign or suspicious.6 The final gene set resulted from a whole genome approach that assessed the 22,000 genes (247,000 transcripts) in the human genome.
- Website
- www.veracyte.com
Work with Veracyte on Scientist.com
For prices, more details, or to contact Veracyte, visit Scientist.com.
Sign in to Scientist.com to open this supplier in your organization's marketplace.